Biography and Research Information
OverviewAI-generated summary
Liam P Alderson's research has focused on the clinical application of dalbavancin, a lipoglycopeptide antibiotic, in the treatment of bone and joint infections. His work includes publications detailing the use of this antibiotic in specific patient populations and infection types. Alderson has collaborated with researchers at the University of Arkansas for Medical Sciences, including Benjamin M. Stronach, Brett Bailey, Ryan K. Dare, and Jennifer L. McDonald, contributing to a shared body of work in this area. His scholarly output to date includes two publications, with a total of three citations and an h-index of 1, indicating early-stage research activity.
Metrics
- h-index: 1
- Publications: 2
- Citations: 3
Selected Publications
-
Dalbavancin Use in Bone and Joint Infections (2024)
Collaboration Network
Top Collaborators
- Dalbavancin Use in Bone and Joint Infections
- 2902. Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
- 2902. Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
- 2902. Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
- 2902. Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
- 2902. Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
- 2902. Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
- Dalbavancin Use in Bone and Joint Infections
Similar Researchers
Based on overlapping research topics